SCHEDULE 13G/A: George W. LeMaitre Maintains Significant 8.5% Stake in LeMaitre Vascular Inc.

George W. LeMaitre, a U.S. citizen, has filed an amendment to his Schedule 13G, disclosing a beneficial ownership of 8.5% of LeMaitre Vascular Inc.'s common stock as of December 31, 2024.

Summary

• George W. LeMaitre beneficially owns 1,925,929 shares of LeMaitre Vascular Inc. common stock.
• This ownership represents 8.5% of the company's total common stock outstanding.
• The calculation of beneficial ownership is based on 22,549,340 shares of common stock outstanding as of December 31, 2024, as reported by the Issuer.
• The aggregate amount beneficially owned includes 34,619 shares subject to options exercisable within 60 days of December 31, 2024.
• Mr. LeMaitre holds sole voting power and sole dispositive power over all 1,925,929 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a 13G is a factual disclosure, the continued significant stake by a key individual like George W. LeMaitre can be interpreted as a positive sign of confidence in the company, without implying any specific financial performance.

Positives

• The filing indicates a significant and continued ownership stake by George W. LeMaitre, suggesting alignment with shareholder interests.
• The maintenance of an 8.5% stake by a key individual can be viewed positively by investors as a sign of confidence in the company's future.

Risks

• The document itself does not detail specific risks beyond the inherent market risks associated with holding common stock.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This filing is a standard regulatory disclosure of a significant shareholder's stake in a publicly traded company within the medical device industry. It reflects an individual's continued investment in LeMaitre Vascular Inc., a company specializing in vascular devices.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant insider's ownership stake, which can influence investor confidence and perception of alignment between management/insiders and shareholder interests.

Key Dates

Keywords

LeMaitre Vascular Inc., beneficial ownership, Schedule 13G, insider ownership, common stock, SEC filing, LMAT